Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Jefferies Maintains Hold on Bristol-Myers Squibb, Raises Price Target to $51

Author: Benzinga Newsdesk | August 28, 2024 02:44pm

Jefferies analyst Akash Tewari maintains Bristol-Myers Squibb (NYSE:BMY) with a Hold and raises the price target from $49 to $51.

Posted In: BMY